The Zucker diabetic fatty (ZDF) rat is a genetic model in which the homozygous (FA/FA) male animals develop obesity and type 2 diabetes. Morbidity and mortality from cardiovascular complications, due to increased oxidative stress and inflammatory signals, are the hallmarks of type 2 diabetes. The precise molecular mechanism of contractile dysfunction and disease progression remains to be clarified. Therefore, we have investigated molecular and metabolic targets in male ZDF (30–34 weeks old) rat heart compared to age matched Zucker lean (ZL) controls. Hyperglycemia was confirmed by a 4-fold elevation in non-fasting blood glucose (478.43 ± 29.22 mg/dL in ZDF vs. 108.22 ± 2.52 mg/dL in ZL rats). An increase in react...
Type 2 diabetes mellitus is known to double mortality from cardiovascular diseases (CVD), in which o...
Reduced cardiac β-adrenoceptor (β-AR) expression and cardiovascular dysfunction occur in models of h...
Metabolic syndrome (MetS) is a predictor of cardiovascular diseases, commonly associated with oxidat...
The Zucker diabetic fatty (ZDF) rat is a genetic model in which the homozygous (FA/FA) male animals ...
Background/Aims: The Zucker diabetic fatty (ZDF, FA/FA) rat is a genetic model of type 2 diabetes, c...
Aims Type 2 diabetes mellitus (DM) leads to cardiac dysfunction irrespective of hypertension and cor...
Activation of inducible nitric oxide synthase (iNOS) and oxidative stress have been shown to be asso...
Despite the fact that skeletal muscle insulin resistance is the hallmark of type-2 diabetes mellitus...
Diabetes is a growing problem in Canada. Cardiovascular disease (CVD) remains the major cause of mor...
Diabetic hearts are susceptible to damage from inappropriate activation of the renin angiotensin sys...
Background: Inhibition of glucose oxidation during initial reperfusion confers protection against is...
International audienceBackground and aims: Zucker Diabetic Fatty fa/fa (ZDF) rats show signs of diab...
Reduced cardiac β-adrenoceptor (β-AR) expression and cardiovascular dysfunction occur in models of h...
Background: The combination of systemic arterial hypertension and diabetes mellitus (DM) induces gre...
This work was supported by the French National Institute for Health and Medical Research (INSERM), a...
Type 2 diabetes mellitus is known to double mortality from cardiovascular diseases (CVD), in which o...
Reduced cardiac β-adrenoceptor (β-AR) expression and cardiovascular dysfunction occur in models of h...
Metabolic syndrome (MetS) is a predictor of cardiovascular diseases, commonly associated with oxidat...
The Zucker diabetic fatty (ZDF) rat is a genetic model in which the homozygous (FA/FA) male animals ...
Background/Aims: The Zucker diabetic fatty (ZDF, FA/FA) rat is a genetic model of type 2 diabetes, c...
Aims Type 2 diabetes mellitus (DM) leads to cardiac dysfunction irrespective of hypertension and cor...
Activation of inducible nitric oxide synthase (iNOS) and oxidative stress have been shown to be asso...
Despite the fact that skeletal muscle insulin resistance is the hallmark of type-2 diabetes mellitus...
Diabetes is a growing problem in Canada. Cardiovascular disease (CVD) remains the major cause of mor...
Diabetic hearts are susceptible to damage from inappropriate activation of the renin angiotensin sys...
Background: Inhibition of glucose oxidation during initial reperfusion confers protection against is...
International audienceBackground and aims: Zucker Diabetic Fatty fa/fa (ZDF) rats show signs of diab...
Reduced cardiac β-adrenoceptor (β-AR) expression and cardiovascular dysfunction occur in models of h...
Background: The combination of systemic arterial hypertension and diabetes mellitus (DM) induces gre...
This work was supported by the French National Institute for Health and Medical Research (INSERM), a...
Type 2 diabetes mellitus is known to double mortality from cardiovascular diseases (CVD), in which o...
Reduced cardiac β-adrenoceptor (β-AR) expression and cardiovascular dysfunction occur in models of h...
Metabolic syndrome (MetS) is a predictor of cardiovascular diseases, commonly associated with oxidat...